27 - 28 March 2025
Sheraton Boston Hotel, Boston, MA

From Novel Technologies to Clinical Applications

Driving the Next Generation of Multi-Omics Research
27 - 28 March 2025 | Sheraton Boston Hotel, Boston, MA

For Every Patient.

Together, we can accelerate life changing, targeted, treatments.

NextGen Omics & Spatial Biology connects R&D specialists in pharma, biotech, academia and healthcare with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics.

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology. 

NGO US Top Section Imagepng

Explore the NextGen Omics & Spatial Biology US 2025 Programme

Select the area of most interest from the icons below

NextGen Biomed 2025

Advancing Therapeutic Innovation Through Multi-Omics Research  

NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics. 

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology. 

Hear from past attendees of last year's Biologics 2024 conference

Explore the NextGen Omics & Spatial Biology US 2025 Programme

Antibody Society

NextGen Biomed 2025 is supported by our
Scientific Programme Partner The Antibody Society

Omics & Spatial About Button

About

Discover more about our ecosystem of channels for the biologics R&D community

NGO US Attend Image

Attend

Be part of the new wave of Biomed R&D innovation, secure your place now

Partner Image

Partner

Showcase your offering to leading pharma and biotech decision makers

NGO US Whats On Image

What's On

Explore dynamic panels, engaging roundtables, and hands-on workshops

2025 Programme Highlights

Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:

NGS, CLINICAL OMICS & DIAGNOSTICS 
Panel Discussion: Overcoming Multi-Omics Data Harmonisation & Analysis Challenges 

Moderator: RUSLAN SADREYEV, Director of Bioinformatics & Assistant Professor, Massachusetts General Hospital
Panellists: 
ARIDAMAN PANDIT, Senior Principal Research Scientist, AbbVie 
FELIX FRANCIS, Sr. Manager, Data Management and Analytics Technology Lead, Takeda 
LUCA PINELLO, Associate Professor of Pathology, Harvard Medical School 
MEDHI DAMAGHI, Assistant Professor & Group Leader, Stony Brook University 
SIMONA CRISTEA, Head of Genomics Data Science & AI, Dana-Farber Cancer Institute 
LUCAS SCHÜTZ, Chief Operational Officer, AriadneAI 

SINGLE CELL 
Presentation: Comparative Insights In Single Cell RNA-seq & Advances In Large-Scale Multimodal Profiling

ZORA MODRUSAN, Senior Director of NGS, Genentech

SPATIAL MULTI-OMICS
Panel Discussion: Guiding Immuno-Oncology Breakthroughs With Spatial Biology

Moderator: ALINA AINBINDER, Scientific Associate Director, Oncology, Takeda
Panellists:
JASMINE PLUMMER, Director, St. Jude Children’s Research Hospital
JIA-REN LIN, Technical Director of Tissue Imaging Platform, Harvard Medical School
NIR BEN CHETRIT, Assistant Professor, Weill Cornell Medicine
COLLES PRICE, Scientific Associate Director, Takeda
YASSER RIAZALHOSSEINI, Associate Professor & Head of Cancer Genomics, McGill University

CROSS PROGRAMME  
Breakfast Roundtables - with topics including 

•   The Potential Of Multi-Omics In Cell & Gene Therapies
•    New Frontiers In Liquid Biopsies
•    Integrating Single Cell Data Across Samples
•    Overcoming Cell Segmentation Challenges In Multiplex Immunofluorescence Biomarker Imaging
•    Single Cell Multi- Omics Integration– From The Pharma Perspective
•    Safety Biomarkers In The Age Of Spatial Biology
•    Harnessing Spatial Transcriptomics In Immunoscience
•    Spatial Analysis Of Cancer Data
•    Advancing Spatial Biology Using The Complexities Of Immune Cell Interactions In

Key Event Highlights

An unmissable journey awaits you: from celebrated keynote speakers and insightful private roundtables, to an exclusive gala dinner. Discover the moments that will transform your NextGen Omics & Spatial experience. 

Meet Our World Class Speakers

Aleksandra Markovets
Director,
AstraZeneca
Colles Price
Scientific Associate Director,
Takeda
Giorgio Gaglia
Head of Target, Disease and Systems Biology, Sanofi,
Sanofi
Jasmine Plummer
Director,
St Jude Children's Research Hospital
Maxime Dhainaut
Director of Spatial Functional Genomics,
Noetik
Pascaline Mary
Senior Director,
HiFiBiO Therapeutics
Priya Chockalingam
Vice President, Head of Clinical Bioanalytics & Translational Sciences,
Beam Therapeutics
Robert Green
Director, Genomes2People Research Program,
Brigham and Women's Hospital
Simona Cristea
Head of Data Science,
DFCI
Wenning Qin
Senior Vice President Innovation,
eGenesis
Yuchun Guo
Director of Computational Biology and Machine Learning,
Camp4 Therapeutics
Zora Modrusan
Sr. Director NGS,
Genentech
Alexandra Tsolias
Scientist II,
Voyager Therapeutics
Ali Ebrahimi
Associate Director,
Takeda
Alice Wan
Senior Scientist,
Abbvie
Alina Ainbinder
Principal Scientist,
Takeda
Aridaman Pandit
Senior Principal Research Scientist,
Abbvie
Brian Cunningham
Professor,
University of Illinios
Deidre Dalmas Wilk
Director,
GSK
Dongdong Lin
Scientist,
EMD Serono
Elaine Lim
Assistant Professor,
UMass Chan Medical School
Elsa Molina
Director, Single-Cell & Spatial Omics,
Salk Institute
Emre Arslan
Associate Director,
Takeda
Eugean Jiwanmall
Senior Research Analyst,
Independence Blue Cross
Felix Francis
Senior Manager Data Management and Analytics,
Takeda
Gabor Balazsi
Professor,
Stony Brook University
Gang Wu
Associate Member,
St Jude Children's Research Hospital
Guolin Zhang
Principal Scientist,
Sensei Therapeutics
Ioannis Ragoussis
Professor,
McGill university
Iulian Pruteanu-Malinci
Director of Bioinformatics for Pioneering Medicines,
Flagship Pioneering
Jan Schejbal
Senior Scientist I,
AbbVie
Jia-Ren Lin
Director,
LSP, Harvard Medical School
Jun Wang
Associate Professor,
Stony Brook University
Kalotina Machini
Principal Investigator (Variant/Genomics) & Instructor in Pathology,
Harvard University
Kalpana Pillai
Technical Development Principal Scientist,
Genentech
Kieran Campbell
Assistant Professor & Research Group Lead,
University of Toronto & Lunenfeld-Tanenbaum Research Institute
Kimberly Smythe
Scientist,
Fred Hutchinson Cancer Center
Lana Garmire
Associate Professor,
University of Michigan
Leonora Balaj
Assistant Professor,
Massachusetts General Hospital
Limeng Pu
Senior Computational Research Scientist,
St. Jude Children's Research Hospital
Lin Wu
Director, Genome Modification Facility,
Harvard University
Luca Pinello
Associate Professor of Pathology,
HARVARD MEDICAL SCHOOL
Manisha Brahmachary
Associate Director,
Sanofi USA
Manoj Kandpal
Director of Research Bioinformatics,
The Rockefeller University
Marina Bleck
Principal Scientist,
Boehringer Ingelheim Pharmaceuticals, Inc.
Matt Kanke
Senior Scientist,
Amgen
Mehdi Damaghi
Assistant Professor,
Stony Brook University
Mena Kamel
Computational Scientist,
Sanofi
Mike G Makrigiorgos
Director,
Dana-Farber Cancer Institute
Nikolai Slavov
Professor,
Northeastern University
Nir Ben Chetrit
Principal Investigator,
Weill Cornell Medicine
Noriko Satake
Professor,
UC Davis
Priyank Patel
Senior Scientist,
Boehringer Ingelheim RCV GmbH & Co KG
Rajib Schubert
Assistant Professor, KAIST,
KAIST
Rigel Chan
Assistant professor,
UMass Chan Medical School
Ruslan Sadreyev
Director of Bioinformatics,
Massachusetts General Hospital
Ruslan Strogantsev
Staff Scientist,
OHSU
Sammy Ferri-Borgogno
Assistant Professor,
Anderson Cancer Center
Seungpyo Hong
Professor,
University of Wisconsin-Madison
Shoh Asano
Senior Principal Scientist,
Pfizer
Shuqiang Li
Lead Scientist, Translational Immunogenomic Laboratory,
Dana-Farber Cancer Institute
Silvia Siso
Scientist-Pathologist,
AbbVie
Stephen T Wong
Associate Director,
Houston Methodist Hospital
Sydney Lavoie
Principle Scientist,
Pfizer
Theodore Perkins
Senior Scientist,
Ottawa Health Research Institute
Tien Phan-Everson
Scientist II,
Allen Institute for Immunology
William Stephenson
Principal Scientist, Technology,
Genentech
Winston Hide
Associate Professor,
Beth Israel Deaconess Medical Center / Harvard Medical School
Xiang Chen
Associate Member,
St Jude Children's Research Hospital
Xiaofeng Jiang
Senior Scientist,
EMD Serono
Yan Tang
Assistant Professor,
Brigham & Women’s Hospital
Yasser Riazalhosseini
Associate Professor,
McGill University
Yesim Gokmen-Polar
Associate Professor,
Emory University School of Mediicne
Yu Tian
Director II,
Abbvie
Yuhwa Lo
Professor,
University of California
Zhaleh Safikhani
Principal Scientist,
AbbVie
Zongmei Gao
Senior Scientist,
AbbVie
Exact Sciences Logo

"NextGen Omics US 2024 was a great networking opportunity, the meeting aspect of appointment setting was great. Everyone has been so helpful and responsive and ahead of our needs."


Regional Oncogenomic Liaison

Exact Sciences

ScipioBio

 

"The support from the Oxford Global team at NextGen Omics US 2024 was excellent - everyone went beyond to help us, it is rare to experience such support."


Chief Business Officer
Scipio Bio

b6fc1bbe-f2c7-48f4-ab7b-860f705182f9-2-5668375logo-logo-levitasbio-R-full-color-(1)

 

"Very professional and a high dedication to vendor needs and delivering on agreed upon packages. Christian is extremely attentive and customer driven, and this is also demonstrated by the Oxford Global team."

Senior Product Marketing Manager
Levitasbio

BD Logo-1

 

"NextGen Omics US was well organised, with highly relevant and engaged attendees."


Senior Sales Specialist, Single-Cell Multiomics
Business Development Manager – Northern Europe, Canopy Biosciences® – A Bruker Company

Allumiqs

 

"NextGen Omics US 2024 was a great, we got good value out of it and are considering coming back to another event!"


Digital Marketing Manager

Allumiqs

Interested in Sponsoring NextGen Omics & Spatial Biology US 2025?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Interested in Sponsoring NextGen Omics & Spatial Biology US 2025?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.

New Opportunities

The Start-up Zone

Are you developing a cutting-edge therapy, platform or technology? Our Start-Up Zone is designed to support emerging companies looking to increase their visibility, find potential partners or early adopters, and meet their investment goals – connecting them with our community of pharma, investors, and mid-to-large size biotechs. 

Located in the Exhibition Hall, the Start-Up Zone allows therapeutic pioneers to showcase their approach, conduct invaluable 1:1 meetings and deliver a quick-fire pitch.

Criteria:

The Start-Up Zone is designed for therapeutic start-ups, academic spin-outs, and early-stage technology/service providers.

To be eligible for inclusion, you must meet the following criteria:

•    0 – 5 years operating
•    0 – 30 employees
•    Pre-Series A funding

Successful applicants will receive as part of their package:

•    1 full conference pass
•    10-minute pitch on the Start-Up Stage
•    1x1m space in Start-Up Zone: cocktail table provided, start-up to bring 1x pull-up banner
•    Logo featured on website & event platform as a participating start-up
•    Ability to arrange 1:1 meetings via to the congress app

2025 Young Scientist Awards (YSA) for Best Poster Presentation

The NextGen Biomed Young Scientist Awards include the best poster presentation award and are intended to honour an outstanding individual performance for a scientific work by a PhD student, PostDoc or early career scientist.

Please submit your poster presentation by no later than 13th January 2025 in the below category:

  • Protein/Antibody Engineering
  • Bioanalysis & Characterisation
  • Next Generation Biotherapeutics
  • Peptides Chemistry & Therapeutics
  • Oligonucleotides Chemistry & Therapeutics
  • Sustainable Chemistry & Manufacturing
  • Student (PhD), PostDoc or early career scientist under 35 years of age. Proof must be provided via an active student ID card or a copy of status
  • Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 13th January 2025
  • ONLY ONE YSA submission per person will be accepted. If authors submit multiple abstracts for consideration for the YSA, only one abstract will be taken into consideration for the YSA

Applicants must follow the procedure as follows: 

  • Register and submit an abstract by 13th January 2025 using the registration link to the left on this page 
  • Once registered you will be provided with the online abstract submission form 
  • Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.) 
  • The 3 winners with the highest scores will be announced at the Networking Drinks on the second day of the event 
  • The winners’ 10-minute oral presentations will take place during the networking drinks on day 2 

The platform or poster presentation will be evaluated by senior scientists (consisting of our speaking and steering group committee for the NextGen Biomed series) on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). All participants will receive the scoring and comments after the annual meeting via email.

The 3 winners receiving the highest scores will be announced at the Networking Drinks on the Day 2 and will be given a trophy as well as £1,000 contribution towards travel costs. Oxford Global will also provide winners with PLUS Pass – 12 months access to our content platform providing access to on-demand presentations, exclusive reports and highlights. 

Plan Your Visit

Sheraton Boston Hotel
39 Dalton Street, Boston, Massachusetts, USA, 02199

Directions

 

By Air
The Sheraton Boston Hotel is conveniently located near Boston Logan International Airport (BOS), just a 15–20-minute drive away.

  • By Public Transport: Take the SL1 (Silver Line) bus from the airport to South Station (free). From South Station, transfer to the MBTA Green Line (E Branch) towards Heath Street and alight at Prudential Station, a short walk from the hotel.
  • By Shuttle Service: Airport shuttles are available; book in advance for door-to-door service.

For more information on airport services, visit the Logan International Airport website.

 

By Tram
Take the Green Line (B, C, or D) to Hynes Convention Center Station. The hotel is a short 3-minute walk from the station. Exit the station, head west along Massachusetts Avenue, and you’ll see the hotel on Dalton Street.

 

By Bus
Several MBTA bus routes stop near the hotel. Use routes 1, 39, or 55 to reach the Hynes Convention Center area. From the bus stop, it’s a quick walk to the hotel on Dalton Street.


Plan your trip using the MBTA website or app for real-time schedules.

 

By Rail
Getting to the Sheraton Boston Hotel by rail is simple and convenient. The hotel is located near major train stations in Boston, making it easily accessible. If arriving via Amtrak, disembark at Back Bay Station, which is just a 10-minute walk from the hotel. Alternatively, you can take a short taxi or rideshare trip. For those travelling on the MBTA Commuter Rail, Back Bay Station also serves as a central hub.


If you arrive at South Station, Boston’s main rail terminal, you can transfer to the Orange Line subway and travel to Back Bay Station in approximately 5 minutes. From there, follow the walking route to the Sheraton Boston Hotel. For added convenience, the hotel is also connected to the Prudential Center, which has easy access points if you’re navigating through the city’s pedestrian pathways.

Be sure to check train schedules and plan your journey ahead. For detailed directions, refer to the MBTA or Amtrak websites.

 

By Car

The Sheraton Boston Hotel is conveniently located in the heart of Boston, at 39 Dalton Street. For the easiest route, we recommend using GPS for real-time directions, ensuring an efficient journey.

When travelling by car, consider that the surrounding area can experience heavy traffic, especially during peak hours. It’s advisable to allow extra time for travel to account for potential delays.


Tip
: Due to Boston's busy streets and ongoing construction, we suggest checking traffic updates and planning your route in advance.

 

Parking

Sheraton Boston offers valet parking at a daily rate of $70. More details can be found on their website here.

Ensure to check for any changes or availability via the hotel's website.

Oxford Global does not have any contracted rooms at the Sheraton Boston Hotel. However, the hotel should have rooms available at their standard rates. We encourage you to contact the hotel directly for availability and pricing.

 

Below is a list of nearby hotels that you may find convenient for your stay:

Please note: While we have provided this list for your convenience, we strongly recommend conducting independent research to ensure that the accommodation suits your specific needs and preferences. Rates and availability may vary, so we suggest booking early to secure your stay.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2025, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of NextGen Omics & Spatial Biology US 2025 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Interested in NextGen Omics & Spatial Biology US 2025?